Publicação científica trimestral do CREMERJ - número 3 - 2022

91 Med. Ciên. e Arte , Rio de Janeiro, v.1, n.3, p.49-93, jul-set 2022 Doença associada à infecção pelo Clostridioides difficile . Atualização Nelson Gonçalves Pereira et al. 7. Khanna S. My treatment Approach to Clostridioides difficile Infection. Mayo Clin Proc, august 2021: 96 (8):2192-2204. 8. Prehn J van, et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 updates on the treatment guidance document for Clostridioides difficile infection in adults. Clinical Microbiology and Infection In Press Corrected Proof Published online: October 13, 2021. 9. Abad CLR & Safdar N. A review of Clostridioides difficile infection and antibiotic associated diarrhea. Gastroenterol Clin N Am 50 (2021): 323. 10. Mc Donald LC & Kutty PK. Clostridioides difficile Infection: Prevention and Control 2021, UPTODATE acessado em 29/09/2021. 11. Simor AE. Diagnosis management, and prevention of Clostridium difficile infection in long-term care facilities: a review. JAGS (2010), 58:1556-1564. 12. NICE. Clostridioides difficile Infection: antimicrobial prescribing. NICE Guideline publicado em 23 july 2021, www.nice.org.uk/guidance/ng199 13. Red Book Clostridioides difficile (formerly Clostridium difficile) 271-276, Report of the Committee on Infectious Diseases 2021-2024, American Academy of Pediatrics. 14. Tougas SR, et al. Prevalence of detection of Clostridioides difficile among assintomatic children. A systematic review and meta-analysis. JAMA Pediatr, 2021: 175(10). doi:10100/jamapediatrics.2021.2328, aug 2021. 15. Davidovics ZH, et al. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A joint position Paper from The North American Society for Pediatric Gastroenterology, hepatology, and Nutrition and the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. JPGN 2019: 68(1): 130-141. 16. McCollun DL & Rodriguez M. Detection, treatment, and prevention of Clostridium difficile infection. Cli Gastroenterol Hepatol (2012), 10: 581-592. 17. Crews DJ. Clostridioides difficilei infection in children. Clinical features and diagnosis. UPTODATE, 2021, acessado em18-12-2021. 18. Poylin V, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the management of Clostridioides difficile Infection. Dis Colon Rectum, 2021: 64:650-668. 19. Tscshudin-Sutter S, et al. Guidance document for prevention of Clostridium difficile infection in acute healthcare settings. Clinical Microbiology and Infection, 24 (2018), 1051-154. 20. Vecchio AL & Zacur GM. Clostridium difficile infection: un update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol (2012) 28:1-9. 21. Safdar N. Clostridium difficile : the emerging epidemic. Mayo Clin Proc, (2012): 87(11):1037-1039. 22. Ananthakrishnan AN, Issa M & Binion DG. Clostridium difficile and inflamatory bowel disease. Gastroenterol Clin N Am (2009), 38:711-728. 23. Peniche AG, Savidge TO & Dann SM. Recent insights into Clostridium difficile pathogenesis. Curr Opin Infect Dis (2013), 26:447-453. 24. Barcan L, et al. Recomendaciones intersociedades para diagnostico, tratamento y prevención de las infecciones por Clostridioides difficile. Medicina (Buenos Aires), 2020: 80:1-32. 25. Zilberberg MD & Shorr AF. Preventing Clostridium difficile infection in the intensive care unit. Crit Care Clin (2013), 29:11-18. 26. Kordus SL, Thomas AK & Lacy DO. Clostridioides difficile toxins and antitoxin therapeutics. Nature Reviews Microbiology, doi.org/10.1038s41579-021-00600-2. 27. Bartlett JG. Antibiotic Associated Diarrhea. N Engl J Med (2002): 346(5): 334-339. 28. Thielman NM&Wilson KH. Antibiotic associated colitis. Cap 96, pg 1375-1387, In Principles and practice of infectious diseases, Mandell GL, Bennett JE & Dolin R, seventh edition, Churchill Livingstone, Philadelphia, 2009.